Swisse-Grape Seed 180 Tablets

Product Description

Swisse Ultiboost Grape Seed is a premium quality formula to support collagen formation, provide antioxidant support and help relieve swelling of the legs.

Collagen Production: Vitamin C plays an integral role in the formation of collagen. Collagen is a major structural protein, important for strong connective tissue to help maintain skin integrity and appearance.

Skin Health: Vitamin C helps the formation of connective tissue and supports the healing process of minor wounds.

Potent Antioxidant: The antioxidant properties of grape seed and vitamin C help protect against free radical damage. Grape seeds contain high levels of procyanidins, anaturally occurring bioflavonoid, also found in fruits and vegetables.

Relieve Swelling: Grape seed helps relieve swelling (oedema), heaviness, pain and itching of the legs.

Swisse Ultiboost Grape Seed has been formulated based on scientific evidence to provide a multi-purpose formula in a convenient dose.

Active Ingredients

Grape Seed (Vitis vinifera) standardised extract equiv. dry seed 14.25 g (equiv. procyanidins 95 mg)

Vitamin C (ascorbic acid) 22.5 mg (from calcium ascorbate dihydrate 27.23 mg)

** No added gluten, lactose, egg, yeast, preservatives and artificial flavours.

Directions For Use

Two tablets daily, during or immediately after a meal, or as directed by a healthcare professional.

Warning

Always read the label.

Use only as directed.

If symptoms persist, see your healthcare practitioner.

About Swisse

Swisse is an Australian success story. It all began with founder Kevin Ring in a humble Melbourne warehouse in 1969. From the outset, our mission was embedded in the Swisse DNA - a dream to make people all over the world healthier and happier. Today, the Swisse product range stretches from top selling men's and women's multivitamins and dietary supplements, to sports nutrition, skincare and functional foods. Swisse products are currently available in Australia, New Zealand, China, Singapore, the UK, Italy and the Netherlands, with plans to launch in up to 30 countries in the next five years.